NME4 Human belongs to the NME/NM23 family of NDKs, which regulate nucleotide homeostasis and mitochondrial physiology.
Nucleotide Metabolism
Mitochondrial Membrane Dynamics
NME4 Human is implicated in lipid metabolism and metabolic disorders:
NME4 Human exhibits dual roles in tumor progression:
HFD Mouse Models: NME4 knockdown via AAV-shRNA reduces hepatic TG levels and NAFLD severity .
In Vitro Studies: NME4 overexpression in liver cell lines increases lipid droplets, while depletion reduces cholesterol and TG levels .
NME4, also known as NDPK-M or NM23-H4, is a nucleoside diphosphate kinase belonging to the nonmetastatic 23 (NM23) family. It specifically localizes to the mitochondrial intermembrane space via its N-terminal sequence, which must be cleaved to enable its catalytic activity. In human cells, NME4 is widely expressed at high levels in the liver, intermediate levels in the heart and colon, and lower levels in the brain, testis, and peripheral leukocytes .
The primary functions of NME4 include:
Regulation of lipid metabolism through interaction with key enzymes in CoA metabolism
Modulation of acetyl-CoA and malonyl-CoA levels
Influence on triglyceride synthesis and accumulation
Potential roles in mitochondrial function and energy metabolism
NME4 binds to the inner mitochondrial membrane via anionic phospholipids, particularly cardiolipin, which positions it strategically for its role in cellular metabolism .
NME4 demonstrates tissue-specific expression patterns in humans. The most reliable detection techniques for studying NME4 expression across tissues include:
RT-qPCR: For quantitative measurement of mRNA expression levels, which has revealed high expression in liver tissue, moderate in heart and colon, and lower levels in brain, testis, and leukocytes .
Western blotting: For protein detection, using specific antibodies against NME4.
Immunohistochemistry: For visualization of NME4 in tissue sections, enabling analysis of its spatial distribution.
Tandem mass spectrometry: For precise protein identification and quantification, which has been successfully applied to identify over 8,000 proteins in NME4 knockout studies .
When designing experiments to measure NME4 expression, researchers should consider analyzing multiple tissue types simultaneously and include appropriate housekeeping genes or proteins as controls for normalization.
NME4 specifically localizes to the mitochondrial intermembrane space and plays a role in mitochondrial metabolism. Research has shown that:
To study this relationship experimentally, researchers should consider:
Mitochondrial isolation techniques to study NME4 localization
Oxygen consumption measurements to assess mitochondrial function
Analysis of mitochondrial membrane potential
Expression analysis of mitochondrial genes in parallel with NME4 expression studies
NME4 plays a significant role in lipid metabolism through multiple mechanisms:
CoA Metabolism Interaction: NME4 interacts with key enzymes in CoA metabolism, influencing acetyl-CoA and malonyl-CoA levels, which are crucial intermediates in fatty acid synthesis .
Triglyceride Regulation: Studies have demonstrated that NME4 increases triglyceride levels and promotes lipid accumulation in the liver. Knockdown of NME4 significantly decreases triglyceride levels in hepatocytes, while overexpression increases them .
NAFLD Progression: NME4 expression positively correlates with the level of steatosis in high-fat diet (HFD) fed mice. NME4 depletion in mouse liver impedes the progression of NAFLD induced by HFD, resulting in decreased liver weight and serum ALT levels (an indicator of liver injury) .
Methodologically, researchers investigating NME4's role in lipid metabolism should consider:
Lipidomic analyses to comprehensively assess changes in lipid profiles
In vitro assays for triglyceride and cholesterol quantification
Targeted gene knockdown or overexpression in hepatic cell lines
In vivo models using liver-specific gene modulation via AAV-mediated delivery
Based on current research, the following experimental models have proven effective:
In vitro models:
Human hepatic cell lines with NME4 knockout or overexpression using CRISPR-Cas9 technology
Primary human hepatocytes treated with fatty acids to induce steatosis
In vivo models:
Liver-specific Nme4 knockdown in mice using AAV-delivered shRNA
High-fat diet (HFD) mouse models to study NAFLD progression
Conditional knockout mouse models for tissue-specific studies
Analytical approaches:
TMT 6plex-based quantitative proteomics for protein expression profiling
Targeted and untargeted lipidomics to comprehensively analyze lipid changes
Metabolomic analyses focusing on acetyl-CoA, malonyl-CoA, and other CoA derivatives
Histological assessment of liver tissue for lipid accumulation
NME4's protein interaction network has been characterized using multiple complementary approaches:
Tandem Affinity Purification Mass Spectrometry (TAP-MS): This technique identified 89 high-confidence interacting proteins (HCIPs) with MUSE scores greater than 0.80 .
Proximity-dependent Biotinylating with Mass Spectrometry (TurboID-MS): This approach helps identify proteins in close proximity to NME4, particularly in the mitochondrial environment .
Key findings from these interaction studies include:
Most NME4 interacting partners are enzymes, kinases, and peptidases
These interactions suggest NME4's regulatory role in metabolic processes
Interacting proteins are highly enriched in pathways related to metabolic diseases and liver complications, including liver steatosis, hyperplasia, and hepatocellular carcinoma
To investigate these interactions experimentally, researchers should consider:
Co-immunoprecipitation studies to validate specific interactions
Proximity labeling approaches for mitochondrial interactions
Functional assays to assess the impact of specific interactions on enzymatic activities
Structural studies to determine interaction domains and binding mechanisms
For effective NME4 gene manipulation, researchers should consider the following approaches based on their specific experimental goals:
For in vitro studies:
CRISPR-Cas9 system: This has been successfully used to generate NME4 knockout cell lines, enabling comprehensive proteomics analysis of the resulting phenotypes .
Lentiviral or plasmid-based overexpression: For gain-of-function studies.
siRNA or shRNA: For transient knockdown experiments.
For in vivo studies:
AAV-mediated shRNA delivery: This approach has been effectively used to knock down Nme4 specifically in the liver, with viral particles primarily targeting hepatocytes rather than adipose tissue .
Conditional knockout models: For tissue-specific and temporally controlled deletion.
Transgenic overexpression: For studying the effects of constitutive or inducible NME4 overexpression.
When designing these experiments, researchers should:
Confirm knockdown or overexpression efficiency at both mRNA and protein levels
Consider potential off-target effects, particularly with CRISPR-Cas9 approaches
Include appropriate controls, such as scrambled shRNA or empty vector controls
Comprehensive analysis of NME4's impact on lipid metabolism requires a multi-omics approach:
Lipidomic analyses:
Untargeted lipidomics can reveal broad changes in the lipidome after NME4 manipulation
Targeted lipidomics should focus on triglycerides, which are significantly affected by NME4
Multiple lipid extraction methods should be employed to ensure comprehensive coverage
Metabolomic analyses:
Targeted quantification of acetyl-CoA and malonyl-CoA, which are directly influenced by NME4
Analysis of CoA derivatives and intermediates in fatty acid synthesis
Stable isotope tracing to track metabolic flux through relevant pathways
Biochemical assays:
In vitro enzymatic assays to measure activities of key lipogenic enzymes
Quantification of cellular triglycerides and cholesterol using commercial kits
Oil Red O staining for visual assessment of lipid accumulation
Integrative approaches:
Correlation of lipidomic data with proteomic changes
Pathway analysis to identify key nodes affected by NME4 manipulation
Network analysis to elucidate the broader metabolic impact
Several complementary proteomics approaches have proven valuable for characterizing NME4's protein interactions and functional networks:
Interaction proteomics:
Tandem Affinity Purification coupled with Mass Spectrometry (TAP-MS): This approach identified 707 proteins, with 89 high-confidence interacting proteins after statistical filtering with the MUSE algorithm .
Proximity-dependent Biotinylation (TurboID-MS): This technique is particularly useful for identifying transient or weak interactions in the native cellular environment, especially within mitochondria .
Co-immunoprecipitation followed by mass spectrometry: For validation of specific interactions.
Quantitative proteomics:
Tandem Mass Tag (TMT) 6plex-based quantitative proteomics: This approach identified over 8,000 proteins and quantified changes in protein expression following NME4 depletion .
Label-free quantification: As an alternative approach for protein quantification.
Targeted proteomics: For precise quantification of specific proteins of interest.
Bioinformatic analysis:
Gene ontology enrichment analysis to identify biological processes affected by NME4
Proteomap analysis to visualize protein expression changes in different functional categories
Network analysis to identify functional modules within the NME4 interactome
When implementing these approaches, researchers should consider:
Appropriate controls to distinguish true interactors from background
Statistical filtering methods like MUSE to increase confidence in interaction data
Validation of key interactions through orthogonal methods
This complex question requires integrative research approaches:
Comparative expression analysis:
Analysis of NME4 expression in healthy versus diseased human tissues (particularly liver)
Correlation of expression levels with disease progression markers
Single-cell RNA sequencing to identify cell-type specific changes in expression
Functional alterations:
Investigation of post-translational modifications of NME4 in disease states
Analysis of subcellular localization changes in pathological conditions
Assessment of catalytic activity alterations in disease models
Interactome changes:
Comparative interaction proteomics between normal and diseased states
Analysis of altered protein complex formation
Investigation of pathway rewiring in pathological conditions
Research has shown that Nme4 expression is positively correlated with steatosis levels in HFD-fed mice, suggesting upregulation in pathological states . Further studies in human samples are needed to fully characterize these changes and their functional implications.
Based on current understanding of NME4's role in lipid metabolism and NAFLD progression, several potential therapeutic approaches could be explored:
Direct inhibition approaches:
Small molecule inhibitors targeting NME4's catalytic activity
Allosteric modulators affecting its protein-protein interactions
Peptide-based inhibitors targeting specific interaction domains
Gene therapy approaches:
AAV-mediated liver-specific knockdown, which has shown promising results in mouse models
CRISPR-based approaches for targeted gene editing
Antisense oligonucleotides for transient knockdown
Metabolic bypass strategies:
Interventions targeting downstream metabolic pathways affected by NME4
Supplementation with metabolites to counteract NME4-induced changes
Combination therapies:
Synergistic approaches combining NME4 modulation with other metabolic interventions
Diet and lifestyle modifications to complement molecular interventions
For researchers pursuing these approaches, careful consideration of off-target effects, tissue specificity, and long-term consequences is essential. Preclinical studies should include comprehensive assessment of both efficacy and safety parameters.
While current NME4 research has primarily used cell and animal models, translation to human studies requires careful design considerations:
Observational studies:
Cross-sectional studies comparing NME4 expression between healthy individuals and those with metabolic disorders
Longitudinal studies tracking NME4 expression over disease progression
Correlation analyses between NME4 levels and established biomarkers of metabolic disease
Clinical sample analysis:
Liver biopsies from patients with various stages of NAFLD for NME4 expression analysis
Multi-omics profiling of patient samples to correlate NME4 with broader metabolic signatures
Single-cell analyses to identify cell-type specific alterations
Biomarker development:
Assessment of NME4 or its downstream effectors as potential diagnostic or prognostic biomarkers
Longitudinal evaluation of candidate biomarkers during disease progression
Correlation with treatment response markers
Intervention studies:
Pharmacological interventions targeting pathways related to NME4 function
Dietary interventions that might modulate NME4 activity or expression
Traceable human experiment design research (THEDRE) methodology for well-controlled human studies
When designing such studies, researchers should consider the principles of human-centered research as outlined in the Traceable Human Experiment Design Research framework, which provides methodological guidance for conducting human-centered informatics research .
NME4's mitochondrial localization places it within a complex network of mitochondrial proteins involved in energy metabolism. To investigate these relationships:
Mitochondrial interactome analysis:
Proximity labeling specifically within mitochondria using mitochondrially-targeted TurboID
Comparison of NME4 interactors with known mitochondrial protein complexes
Analysis of co-expression patterns across tissues and conditions
Functional relationships:
Assessment of how NME4 manipulation affects other mitochondrial functions
Investigation of potential coordination between NME4 and mitochondrial lipid metabolism
Analysis of energy production pathways in the context of NME4 activity
Evolutionary perspectives:
Comparative analysis of NME4 function across species
Assessment of co-evolution with interacting mitochondrial proteins
Identification of conserved functional domains and interaction motifs
Advanced computational approaches can help elucidate NME4's role in broader metabolic networks:
Network modeling approaches:
Protein-protein interaction network analysis incorporating NME4 interactome data
Metabolic flux balance analysis to predict the impact of NME4 modulation
Bayesian network modeling to infer causal relationships in metabolic pathways
Machine learning applications:
Predictive models of NME4's impact on cellular phenotypes
Feature selection to identify key factors influenced by NME4
Pattern recognition in multi-omics data sets related to NME4 function
Systems biology integration:
Multi-scale modeling incorporating molecular, cellular, and tissue-level data
Dynamic simulation of metabolic responses to NME4 perturbation
Integration of experimental data with existing metabolic models
Researchers should validate computational predictions with targeted experimental approaches, creating an iterative cycle of prediction, validation, and model refinement.
Scientific literature may contain seemingly contradictory findings about NME4 function. To address these contradictions:
Standardization approaches:
Establish consistent experimental protocols for NME4 research
Define standard cell lines and animal models for comparative studies
Create reference datasets for NME4 expression and function
Contextual analysis:
Systematically investigate context-dependent functions of NME4
Identify factors that may explain differential effects (cell type, metabolic state, etc.)
Design experiments that explicitly test the influence of contextual factors
Meta-analysis techniques:
Systematic review of existing literature to identify patterns in contradictory findings
Statistical meta-analysis of comparable datasets
Identification of moderator variables that explain heterogeneity in results
Direct replication and extension:
Independent replication of key experiments using identical methods
Systematic variation of experimental parameters to identify boundary conditions
Collaborative multi-lab studies to increase robustness of findings
By addressing contradictions systematically, researchers can develop a more nuanced understanding of NME4's complex roles in human cellular metabolism.
Non-Metastatic Cells 4 (NME4), also known as NM23-H4, is a member of the NME/NM23 family of nucleoside diphosphate kinases (NDKs). These proteins are involved in various cellular processes, including proliferation, differentiation, and apoptosis. NME4 is particularly notable for its role in mitochondrial function and cellular energy metabolism.
NME4 is a mitochondrial protein that possesses nucleoside diphosphate kinase activity. This activity is crucial for maintaining the balance of nucleoside triphosphates and diphosphates within the cell. The protein is encoded by the NME4 gene, which is located on chromosome 16 in humans. Structurally, NME4 shares a high degree of similarity with other members of the NME family, particularly in its catalytic domain.
NME4 plays a significant role in several cellular processes:
NME4 has been studied in the context of various diseases, particularly cancer. Its role in mitochondrial function and apoptosis makes it a potential target for cancer therapy. Alterations in the expression or function of NME4 have been associated with several types of cancer, including breast cancer and colorectal cancer. Research is ongoing to understand the precise mechanisms by which NME4 influences cancer progression and to develop therapeutic strategies targeting this protein.